{
    "2018-12-24": [
        [
            {
                "time": "2018-12-24",
                "original_text": "After Hours Most Active for Dec 24, 2018: S, QQQ, SQQQ, KGC, PLNT, PFE, BAC, MU, QSR, INTC, IEF, SLM",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE",
                        "BAC",
                        "INTC"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "How Pfizer’s Sutent and Xalkori Have Performed",
                "features": {
                    "keywords": [
                        "Sutent",
                        "Xalkori",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "This Drug Is Expected to Be a Significant Driver for Pfizer",
                "features": {
                    "keywords": [
                        "Drug",
                        "Significant Driver",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "How Pfizer’s Oncology Business Is Positioned",
                "features": {
                    "keywords": [
                        "Oncology",
                        "Business",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "Health Care Sector Update for 12/24/2018: ACOR, CDXC, RDY, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "PFE",
                        "JNJ"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "Pfizer/Merck KGaA End Bavencio Ovarian Cancer Phase III Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Merck KGaA",
                        "Bavencio",
                        "Phase III",
                        "Study"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "Pfizer Falls 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Falls"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}